🇺🇸 FDA
Patent

US 8242305

Process to prepare treprostinil, the active ingredient in remodulin

granted A61KA61K31/192A61P

Quick answer

US patent 8242305 (Process to prepare treprostinil, the active ingredient in remodulin) held by United Therapeutics Corporation expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Therapeutics Corporation
Grant date
Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/192, A61P, A61P1/00, A61P1/14